Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group.
about
Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomasRadiotherapy protocol deviations and clinical outcomes: a meta-analysis of cooperative group clinical trialsWhat we have learned: the impact of quality from a clinical trials perspectiveCompliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.What is new in the biology and treatment of pediatric rhabdomyosarcoma?Rhabdomyosarcoma in infants younger than 1 year: a report from the Children's Oncology Group.Delayed primary excision with subsequent modification of radiotherapy dose for intermediate-risk rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children's Oncology Group D9602 studyRadiotherapy quality assurance report from children's oncology group AHOD0031Rheumatologists' adherence to a disease activity score steered treatment protocol in early arthritis patients is less if the target is remission.Consensus and controversies regarding the treatment of rhabdomyosarcoma.
P2860
Q26825000-25DC91C4-BF40-4D09-8CB7-DB8AAADD3EBEQ26828964-3FCC7995-7DAF-428A-B08E-174793CCD6A8Q27008209-190888AE-C995-4B7A-86D1-8BCC59B1C1B9Q30411811-11305283-1881-4C24-BC21-B2E26C8D0A18Q33895506-E11B2D2F-4627-4EF8-8F52-A443465102AAQ35119012-E7854C61-2853-4112-BE8D-6081077EC42BQ35760674-4B56917C-10B8-42A4-A075-5643AF68F2ADQ35834688-66FAF118-8820-4B21-9F09-440213533216Q37590108-B400E442-86D4-47FA-9A6B-6C329F216F1BQ37622216-514E056E-02CF-4224-803F-A6EB76794F55Q47687872-BB45C274-5A97-4B9C-AB2D-A1145E68D5AC
P2860
Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children's Oncology Group.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Influence of noncompliance wit ...... the Children's Oncology Group.
@en
Influence of noncompliance wit ...... the Children's Oncology Group.
@nl
type
label
Influence of noncompliance wit ...... the Children's Oncology Group.
@en
Influence of noncompliance wit ...... the Children's Oncology Group.
@nl
prefLabel
Influence of noncompliance wit ...... the Children's Oncology Group.
@en
Influence of noncompliance wit ...... the Children's Oncology Group.
@nl
P2093
P2860
P1476
Influence of noncompliance wit ...... the Children's Oncology Group.
@en
P2093
David Rodeberg
Douglas S Hawkins
Fran Laurie
James Anderson
Jeff Michalski
John Breneman
Lynn Million
Moody Wharam
Sarah S Donaldson
Soft Tissue Sarcoma Committee of the Children's Oncology Group
P2860
P304
P356
10.1016/J.IJROBP.2010.01.058
P407
P577
2010-06-18T00:00:00Z